Can Ella (ulipristal acetate) be used instead of Plan B (levonorgestrel) for emergency contraception?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ella (Ulipristal Acetate) vs Plan B (Levonorgestrel) for Emergency Contraception

Ella (ulipristal acetate) is more effective than Plan B (levonorgestrel) for emergency contraception, especially when taken between 72-120 hours after unprotected intercourse and for women who are overweight or obese. 1, 2

Comparative Effectiveness

Timeframe Considerations

  • 0-72 hours after intercourse:

    • Ulipristal acetate prevents approximately 85% of expected pregnancies 2
    • Levonorgestrel prevents approximately 75-80% of expected pregnancies 2
    • Meta-analysis showed ulipristal acetate has a 42% lower pregnancy risk than levonorgestrel within 72 hours 3
    • In the first 24 hours, ulipristal acetate has a 65% lower pregnancy risk than levonorgestrel 3
  • 72-120 hours after intercourse:

    • Ulipristal acetate remains effective up to 120 hours (5 days) 2, 4
    • Levonorgestrel's effectiveness significantly decreases after 72 hours 2
    • Clinical trials showed no pregnancies when ulipristal acetate was administered more than 72 hours after intercourse 4

Body Weight Considerations

  • For women with BMI > 30 kg/m²:
    • Ulipristal acetate: 3.1% observed pregnancy rate 4
    • Levonorgestrel: 7.4% observed pregnancy rate 4
    • Ulipristal acetate is preferable for women weighing more than 75 kg or with BMI > 25 kg/m² 5

Mechanism of Action

  • Ulipristal acetate (Ella):

    • Selective progesterone receptor modulator 4
    • Can delay or inhibit ovulation even 24-48 hours before expected ovulation 6
    • Primary mechanism is inhibition/delay of ovulation; may also affect endometrium 4
  • Levonorgestrel (Plan B):

    • Progestin-only emergency contraceptive 3
    • Less effective at delaying ovulation when taken close to ovulation 6

Safety Profile

  • Both medications have similar side effect profiles 7, 8
  • Common side effects include:
    • Headache (approximately 19% for both medications) 8
    • Nausea
    • Breast tenderness
    • Delayed menses by 2-3 days 7

Practical Considerations

  • Prescription requirements:

    • Ulipristal acetate (Ella) requires a prescription 3
    • Levonorgestrel (Plan B) is available over-the-counter for all ages 5
  • Subsequent hormonal contraception:

    • After using Ella, wait at least 5 days before starting hormonal contraception 4
    • Use a reliable barrier method until the next menstrual period 4

Clinical Decision Algorithm

  1. If within 120 hours of unprotected intercourse:

    • First choice: Ulipristal acetate (Ella), especially if:
      • More than 72 hours have passed
      • Patient has BMI > 25 kg/m²
      • Close to expected ovulation
  2. If within 72 hours and normal BMI:

    • Either medication is effective, but ulipristal acetate has slightly better efficacy
  3. If no prescription access is available:

    • Levonorgestrel (Plan B) is appropriate if within 72 hours
  4. For maximum effectiveness:

    • Consider copper IUD (>99% effective) if appropriate for the patient 2

Important Caveats

  • Neither medication is effective if taken after ovulation has already occurred 5
  • Both medications should be taken as soon as possible after unprotected intercourse 2
  • The CDC supports advance provision of emergency contraceptive pills 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Contraception

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Update on emergency contraception.

Advances in therapy, 2011

Research

Emergency Contraception.

Mayo Clinic proceedings, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.